Back to search

Article

COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis

2021-11-30

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., p ost- C OVID-19 l ung d isease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. <h4>Method</h4> Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ec32ca70-6737-5921-a6d2-9af8ca123620
DOI
10.1101/2021.11.28.470269
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosisDOI 10.1101/2021.11.28.470269
Select a neighboring publication to make it the new centre.